Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections

Mumbai: Wockhardt has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel antibacterial agent Zidebactam-Cefepime injection (WCK 5222, ZAYNICH).…

Continue ReadingWockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections

Real-World Case Insight: Triple FDC Therapy in a Young Diabetes Patient – Dr Naresh Kumar

In this video, Dr. Naresh Kumar, Consultant Diabetologist from Tamil Nadu, presents a real-world case of a 24-year-old male student with fatigue and polyuria, diagnosed with type 2 diabetes mellitus…

Continue ReadingReal-World Case Insight: Triple FDC Therapy in a Young Diabetes Patient – Dr Naresh Kumar

Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US

Bengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd.,  has announced a settlement and license agreement with Amgen Inc. that clears the path for the commercialization…

Continue ReadingBiocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US